A randomised double blind placebo controlled trial of the addition of metformin to optimal treatment in patients with chronic heart failure. Assessment by regional haemodynamics neurohumoral activation and symptomatic well being

Not Applicable

Completed

• Conditions: Cardiovascular: Congestive heart failure (CHF); Circulatory System; Heart failure

• Registration Number: ISRCTN22334267
• Lead Sponsor: Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Total number of subjects = 20

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Regional haemodynamics<br>2. Neurohumoral<br>3. Symptomatic well being

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration